LSI Industries Inc (LYTS) reports impressive year-over-year sales growth and significant debt reduction, despite challenges ...

Q2 2025 Earnings Call Transcript January 23, 2025 LSI Industries Inc. misses on earnings expectations. Reported EPS is $0.18 ...

Greetings and welcome to LSI Industries' fiscal 2025 second-quarter results conference call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the ...

Analyst Amit Dayal of H.C. Wainwright maintained a Buy rating on Lsi Industries (LYTS – Research Report), boosting the price target to ...

Greetings, and welcome to LSI Industries Fiscal 2025 Second Quarter Results Conference Call. At this time, all participants are on a listen-only mode. A question-and-answer session will follow the ...

LSI Industries reported a strong 36% sales growth in Q2 FY25, reaching $147.7 million, surpassing analyst expectations. This growth was fueled by robust demand across vertical markets and the ...

Shares of LSI Industries jumped to a record high after the company's revenue surged in the fiscal second quarter thanks to strong demand and contributions from a recent acquisition.

LSI Industries Inc. (Nasdaq: LYTS, "LSI" or the "Company") a leading U.S. based manufacturer of commercial lighting and display solutions, today reported financial results ...

In a report released today, Aaron Spychalla from Craig-Hallum maintained a Buy rating on Lsi Industries (LYTS – Research Report). The company’s ...

LSI Industries’s dividend payout ratio is currently 25.32%. LSI Industries Inc produces and sells non-residential lighting and retail display solutions in the United States, Canada, Mexico ...

LSI Industries (NASDAQ:LYTS) jumped 11% in premarket trading Thursday after the maker of commercial lighting reported quarterly results that were better than what Wall Street had estimated. Adjusted ...

Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release ...